Five questions for … Dr. Michael Aragones
Kaiser Permanente Southern California has 2 Regional Reference Laboratories, which make up a sophisticated clinical laboratory management system that interfaces with medical centers and medical offices throughout the region. Michael Aragones, MD, is a Research & Evaluation research lab project ...
Featured News
Increasing vaccine equity in Southern California
In addition to bringing isolation and illness to the world, the COVID-19 pandemic spotlighted the health disparities between Southern California communities. Getting COVID-19 vaccines to the neighborhoods ...
Atrial fibrillation may increase risk for dementia
People who have been diagnosed with atrial fibrillation are known to have an increased risk of developing other heart problems. A new Kaiser Permanente study suggests they may also be at increased risk ...
Paxlovid associated with lower risk of hospital admission
A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless ...
5 questions for … Dr. Sonya Negriff
August 10, 2021Sonya Negriff, PhD, is a developmental psychologist with expertise in the effects of child maltreatment on physical and mental health. She has been with the Department of Research & Evaluation for 3 years. Dr. Negriff examines the pathways linking child maltreatment to negative outcomes such as depression, post-traumatic stress disorder, substance use, obesity, and sexual ...Read more...Where you live may affect your long-term survival after heart attack
August 2, 2021A study of more than 31,000 Kaiser Permanente members in Southern California showed that Black patients from disadvantaged neighborhoods were significantly more likely to die within 5 years of surviving a heart attack than white patients. In contrast, there was no difference in rates of death between white patients and Black patients who lived in ...Read more...COVID-19 vaccine trials for children are underway
July 30, 2021When their parents asked if they wanted to be part of a COVID-19 vaccine trial for children, Aidan and Avery Shih didn’t have to think about it for long. Both were eager to help end the pandemic. “The vaccine does help you not get COVID, of course, but then also it helps you so you don't spread COVID. So, if enough people get the vaccine, COVID will slow and hopefully eventually stop,” said Aidan, 11.Read more...New protocol allows teen to go home same day as chest surgery
July 27, 2021About 5 years ago, John Connell, now 16, was at a water park when a friend pointed his index finger at John’s bare chest and asked, “Were you in a car accident or something?” John looked down at his chest, and then at the chests of the other boys around him, and realized for the first ...Read more...Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19
July 23, 2021Hospitalized adults who have COVID-19 are more than 3 times as likely to develop a blood clot than adults who do not have COVID-19, according to new research from Kaiser Permanente Southern California and Kaiser Permanente Northern California. The study published July 20 in CHEST found Black patients as well as patients who had obesity, liver ...Read more...5 questions for … Dr. Erin Hahn
June 28, 2021Erin E. Hahn, PHD, MPH, is a health services researcher and implementation scientist. Her primary research interests are quality of care in oncology and the implementation of evidence-informed practices. She is particularly interested in the care of cancer survivors after their initial cancer treatment. Dr. Hahn joined the Department of Research & Evaluation as the ...Read more...Rates of heart failure deaths lower at Kaiser Permanente Southern California than U.S.
June 28, 2021A Kaiser Permanente Southern California research study found lower rates of heart failure mortality within the integrated health care system compared to the country as a whole. “In our study, we analyzed the overall rates of death attributable to heart failure throughout the state of California and United States, and then compared that to what we ...Read more...Kaiser Permanente Los Angeles Medical Center joins COVID-19 vaccine trial for children
June 11, 2021Kaiser Permanente Los Angeles Medical Center is participating in a clinical trial for the Moderna COVID-19 vaccine in children ages 6 months to less than 12 years. The KidCOVE study will evaluate the safety and efficacy of the Moderna COVID-19 vaccine (mRNA-1273), which is the same vaccine that was given Emergency Use Authorization (EUA) in December ...Read more...Kaiser Permanente Los Angeles Medical Center to study experimental stroke drug
June 4, 2021Kaiser Permanente Los Angeles Medical Center will conduct a multi-centered, randomized, Phase 3 research study to learn if the experimental drug recombinant Factor VIIa (rFVIIA), a protein that our body makes, can be used to decrease bleeding in the brain of patients who suffer sudden bleeding in the brain, also called intracerebral hemorrhage. The study entitled ...Read more...Marking Clinical Trials Day 2021 with gratitude
May 20, 2021On this day—May 20, 2021, aka Clinical Trials Day—we have more reasons than ever to celebrate the Kaiser Permanente Southern California clinical trials team. We began our COVID-19 clinical trials research with the remdesivir trial in March 2020. We were a top enroller in that study. Since then, our clinical trials program has participated in 9 ...Read more...